Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.4226?guestAccessKey=df819b8f-2bea-41e3-a44d-a56c120be434&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092222
JAMAONCO_OF:09152022
JAMAONCO_ADHOC:09122022
JAMAONCO_OF:09082022
JAMAONCO_OF:09012022
Visual Abstract: Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 1, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3829?guestAccessKey=efae0fdc-ee29-440a-bcb1-3851ebb46e11&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090122 Visual Abstract Authors: Thierry…
Visual Abstract: Efficacy, Safety of Telaglenastat Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 1, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3511?guestAccessKey=c6ad7a6b-caf2-411c-a706-d6e65b18d0c6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090122 Visual Abstract…
JAMAONCO_OF:08252022
Reporting of Race and Hispanic Ethnicity in Breast Cancer Studies From the National Cancer Database
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3527?guestAccessKey=df819b8f-2bea-41e3-a44d-a56c120be434&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082522
Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3677?guestAccessKey=14d8ef3b-d59d-4322-aee4-d8ef1be7480d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082522
JAMAONCO_08182022
Visual Abstract: Etoposide, Cisplatin vs Irinotecan, Cisplatin for Neuroendocrine Carcinoma of Digestive System
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 18, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3395?guestAccessKey=686b68ae-7de7-4777-9e3c-13a3fe86deb8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081822 Visual Abstract Authors: Chigusa…
JAMAONC_OF:08112022
Antibody Response of 3-Dose COVID-19 Vaccination Schedule in Immunocompromised Patients With Hematologic Cancers
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 11, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3227?guestAccessKey=0b9a95d7-73d1-49c0-a5a8-c690dae47ecc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081122 About The Study: In this study that included 584…
JAMAONCO_OF:08042022
Association Between PSA Screening, Prostate Cancer Mortality Among Non-Hispanic Black, Non-Hispanic White Veterans
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 4, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2970?guestAccessKey=06430554-cf5a-42e4-b950-adbebba956fa&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=080422 About The Study: In this study of 45,800 U.S….
JAMAONCO_OF:07282022
Daily Insulin Dose, Cancer Risk Among Patients With Type 1 Diabetes
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 28, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2960?guestAccessKey=b87b1296-2d13-4778-adc8-6ef8cfe9425f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072822 About The Study: This study investigated the associations of…
Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2952?guestAccessKey=3997d5dd-38bd-4549-a346-9f6ad30ddf3c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072822
JAMAONCO_OF:07212022
Incidence of Anaplastic Large-Cell Lymphoma of the Breast in US
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2624?guestAccessKey=4c6c9ff4-348c-4a3d-be6d-a933bd35a8b4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072122
JAMAONCO_OF:07142022
Visual Abstract: Preoperative mFOLFIRINOX With vs Without Hypofractionated Radiotheraphy for Borderline Resectable Adenocarcinoma of the Pancreas
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 14, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2319?guestAccessKey=19be8691-33c6-45fa-a57d-449b14057ad6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=071422 Visual Abstract…
JAMAONCO_OF:07072022
Plant-Based, Ketogenic Diets As Diverging Paths to Address Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1769?guestAccessKey=6fcb6393-e7d5-4721-8be2-c93131f59772&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070722
Worldwide Association of COVID-19 Pandemic Measures With Cancer Screening
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 7, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2617?guestAccessKey=bad2cff1-e56b-4697-840b-d5046c557c22&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070722 About The Study: The results of this systematic review…
Visual Abstract: Effect of Community Health Worker Intervention on Acute Care Use in Advanced Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 30, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1997?guestAccessKey=4689aac9-0b9e-49bc-ba6e-af3010634318&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=063022 Visual Abstract…
Visual Abstract: Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 30, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2253?guestAccessKey=d809d096-4cd9-4e27-9c36-c802e22956bd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=063022 Visual Abstract Authors: Ning…
JAMAONCO_OF:06302022
Opioid Management in Individuals With Advanced Cancer-Related Pain, Opioid Misuse or Use Disorder
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 30, 2022 Media advisory: The full study and editorial are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2191?guestAccessKey=5a825031-95be-41f4-8be4-9f3be6dd5772&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=063022 About The Study: The findings of this…
JAMAONCO_ADHOC:06282022
JAMAONCO_OF:06232022
Visual Abstract: Ipilimumab vs FOLFOX in ERBB2-Positive Esophagogastric Adenocarcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 23, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2228?guestAccessKey=88a81f35-fbee-41a3-a7fc-574429ec2cf4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062322 Visual Abstract…
Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race, Ethnicity
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 23, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1990?guestAccessKey=3d042976-b580-42b8-a1f0-341ff4cef611&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062322 About The Study: This study of 45,000…
Environmental Outcomes Associated With Transition From In-Person to Virtual Conference During COVID-19
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 23, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1925?guestAccessKey=9cff5e2e-0789-4421-be52-8d3dd58455a9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062322 About The Study: Researchers estimated the change in travel-related…
JAMAONCO_OF:06162022
Visual Abstract: Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 16, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1641?guestAccessKey=27101ae2-0299-4636-ae46-9e6c928e13e1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061622 Visual Abstract…
Visual Abstract: Efficacy of Pegasparaginase-Based Chemotherapy Regimen vs L-asparaginase–Based Regimen for Extranodal Natural Killer/T-Cell Lymphoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 16, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1968?guestAccessKey=e677efdb-e05c-46f6-9c45-8250fba74408&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061622 Visual Abstract…
Assessing Risk of Maternal Death in Pregnancies Complicated by Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 16, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1795?guestAccessKey=53666fe6-8c61-4ef6-8aa1-925d724bbda0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061622 About The Study: Researchers examined nationwide trends and characteristics…
JAMAONCO_OF:06092022
Risk Factors, Racial, Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1628?guestAccessKey=f59cfb53-9e1c-4d40-8d10-0d77617ef26c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060922
Assessment of Compliance With Centers for Medicare & Medicaid Services Price Transparency Final Rule
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1783?guestAccessKey=ed7608dc-a4c6-4f38-b178-fbec153a9283&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060922
JAMAONCO_OF:06022022
JAMAONCO_OF:05262022
Visual Abstract: Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 26, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1479?guestAccessKey=b74760fc-69e3-4e2a-83f2-8d34a94ca3b3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=052622 Visual Abstract…
JAMAONCO_OF:05242022
JAMAONCO_OF:05192022
Change in Cancer Death Rates Among Black Individuals in US
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 19, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1472?guestAccessKey=4f8298ee-74af-4722-870e-e774477e130c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051922 About The Study: Researchers found in this cross-sectional study…
JAMAONCO_OF:05122022
Visual Abstract: Efficacy of Vistusertib With Anastrozole in Recurrent or Metastatic Endometrial Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 12, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1047?guestAccessKey=7ceee02b-5633-46ea-8090-de65d98f5d50&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051222 Visual Abstract Authors: Pierre…
Visual Abstract: Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer, Brain Metastases
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 12, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0514?guestAccessKey=d16b2127-1557-410e-9965-0bfac3675cb4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051222 Visual Abstract Authors: Debu…
JAMAONCO_OF:05052022
Racial, Ethnic Differences in Uterine Cancer Mortality Rates
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 5, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0009?guestAccessKey=bc521263-d45e-4eb6-8531-4b0b890fd93e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050522 About The Study: This study of 208,000 women showed…
Age at Initiation of Endoscopy, Colorectal Cancer Risk Among Women
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 5, 2022 Media advisory: The full study and editorial are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0883?guestAccessKey=8acc231b-cf2a-4115-ae46-e34a7f3d6497&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050522 About The Study: Compared with no endoscopy,…
JAMAONCO_OF:04282022
JAMAONCO_ADHOC:04222022
Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1467?guestAccessKey=a314a6bb-e264-4ade-86c3-0e104b8f74f9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042222
JAMAONCO_OF:04212022
Durability of Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0752?guestAccessKey=bed65c33-3051-450a-9874-e6858923afd2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042122
JAMAONCO_OF:04142022
JAMAONCO_ADHOC:04082022
Breakthrough SARS-CoV-2 Infections, Hospitalizations, Mortality in Vaccinated Patients With Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1096?guestAccessKey=da1de153-897a-41d6-80f6-14ae617e331a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040822
JAMAONCO_OF:04072022
Association of Medicaid Expansion With Mortality Disparity by Race, Ethnicity Among Patients With De Novo Stage IV Breast Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0159?guestAccessKey=acc01b6e-19ef-42f0-863a-7fcbda037aa6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040722
Association of Pandemic With Rates of Prostate Cancer Biopsies, Diagnoses in Black vs White US Veterans
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 7, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0467?guestAccessKey=92f3e2d1-bd5c-46de-bd55-7c4bb72dcb11&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040722 What The Study Did: Prostate biopsy and prostate cancer…
JAMAONCO_OF:03312022
Visual Abstract: TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 31, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3547?guestAccessKey=8d9bd1e6-f049-42d7-afe3-9c8e25f2daa8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033122 Visual Abstract Authors: Robin…
Association of Patient-Reported Outcomes With Nonfatal Self-injury After New Cancer Diagnosis
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0203?guestAccessKey=00e63a17-6219-47bf-8c53-40a8bd9f6638&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033122
Association of Changes in Medicaid Dental Benefits With Oral Cavity Cancer Diagnosis
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0149?guestAccessKey=6a711b05-104d-497e-9fc0-b0f83e4f049d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033122
JAMAONCO_OF:03242022
Self-reported Transportation Barriers to Health Care Among US Cancer Survivors
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0143?guestAccessKey=5cf125ad-4c75-4c74-8fa2-7e2cc23d7191&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032422
Visual Abstract: Paclitaxel, Cisplatin, Capecitabine vs Cisplatin, Fluorouracil for Nasopharyngeal Carcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 24, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0122?guestAccessKey=0dbfee8b-21aa-4dba-9124-1cad55464019&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032422 Visual Abstract…
JAMAONCO_OF:03172022
Risk of Colorectal Cancer Associated With Lifetime Excess Weight
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 17, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0064?guestAccessKey=f7acd72a-cef3-4048-b6f5-c79e1a5df966&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031722 What The Study Did: A greater number…
JAMAONCO_OF:03102022
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0001?guestAccessKey=28a28d85-7f85-427c-b826-d89f6a8ecb4c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031022
JAMAONCO_OF:03032022
Factors Associated With Racial Disparity in Use of MRI Among Patients With Prostate Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 3, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.8116?guestAccessKey=de4ed44c-76d6-4a00-8162-6f8f7fc66096&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030322 What The Study Did: This study of…
Visual Abstract: Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 3, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.8171?guestAccessKey=89bc130b-ab40-4ac6-88e6-4f65d4a27e5d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030322 Visual Abstract Authors:…
JAMAONCO_OF:02242022
Visual Abstract: Palliative Radiation for Advanced Central Lung Tumors With Avoidance of the Esophagus
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 24, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7664?guestAccessKey=553a7379-6e75-4459-92c7-2ab0b6d97fea&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=022422 Visual Abstract…
Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7656?guestAccessKey=d9c22bbb-19ef-4c43-85f7-afc06c85febc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021722
Visual Abstract: Capecitabine Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 17, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7366?guestAccessKey=1105ab84-3fa2-4968-8fc0-a0a004c7679a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021722 Visual Abstract…
JAMAONCO_OF:02172022
Visual Abstract: Autologous Dendritic Cell Immunotherapy Plus Chemotherapy in Metastatic Castration-Resistant Prostate Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 10, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7298?guestAccessKey=917838c5-d533-4d82-982c-5950df33843b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021022 Visual Abstract…
Visual Abstract: Effect of Symptom Monitoring Intervention for Patients Hospitalized With Advanced Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 10, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7643?guestAccessKey=37d42b48-589a-4d9b-82cc-956b70090d11&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021022 Visual Abstract Authors:…
Association of HPV Vaccination, Incidence of Squamous Cell Carcinomas of Anus
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7652?guestAccessKey=c9a9b5b2-3c4c-405e-8021-ff8ccc302036&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021022
JAMAONCO_OF:02102022
JAMAONC_OF:02032022
JAMAONCO_OF:01272022
Geographic Disparities in Treatment of Curable Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 27, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7337?guestAccessKey=7a16d9be-1ed0-42ab-bdbd-f456a1f31f88&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=012722 What The Study Did: The extent to which geographic…
JAMAONCO_OF:01202022
JAMAONCO_OF:01132022
Comparing Lung Cancer Screening Criteria for Racial Disparity in Eligibility
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 13, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6720?guestAccessKey=46113213-0bcc-4a03-a1c3-c4ea5e7383a2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011322 What The Study Did: The findings of…
JAMAONCO_ADHOC:01072022
SARS-CoV-2 Antibody Response to 2 or 3 Doses of BioNTech-Pfizer Vaccine in Patients With Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, JANUARY 7, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7777?guestAccessKey=64f57de0-65f5-4ccc-9c30-3abe123b5e3b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010722 What The Study Did: This study assessed the antibody…
Visual Abstract: Comparing Prophylactic Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 6, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6628?guestAccessKey=83a5b584-1fa5-48e4-82a9-28d957bdab6d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010622 Visual Abstract…
JAMAONCO_OF:01062022
Association of Sitting Time, Physical Activity With Cancer Survival
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 6, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6590?guestAccessKey=8b888a7b-1d4c-4ddc-94cb-2cd1ef14deb9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010622 What The Study Did: Researchers examined the associations of…